Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0064 Transporter Info
Gene Name	ABCD2
Transporter Name	Adrenoleukodystrophy-like 1
Gene ID	225
UniProt ID	Q9UBJ2

Post-Translational Modification of This DT
Overview of ABCD2 Modification Sites with Functional and Structural Information
Sequence	M T H M L N A A A D R V K W T R S S A A K R A A C L V A A A Y A L K T L Y P I I G K R L K Q S G H G K K K A A A Y P A A E N T E I L H C T E T I C E K P S P G V N A D F F K Q L L E L R K I L F P K L V T T E T G W L C L H S V A L I S R T F L S I Y V A G L D G K I V K S I V E K K P R T F I I K L I K W L M I A I P A T F V N S A I R Y L E C K L A L A F R T R L V D H A Y E T Y F T N Q T Y Y K V I N M D G R L A N P D Q S L T E D I M M F S Q S V A H L Y S N L T K P I L D V M L T S Y T L I Q T A T S R G A S P I G P T L L A G L V V Y A T A K V L K A C S P K F G K L V A E E A H R K G Y L R Y V H S R I I A N V E E I A F Y R G H K V E M K Q L Q K S Y K A L A D Q M N L I L S K R L W Y I M I E Q F L M K Y V W S S S G L I M V A I P I I T A T G F A D G E D G Q K Q V M V S E R T E A F T T A R N L L A S G A D A I E R I M S S Y K E V T E L A G Y T A R V Y N M F W V F D E V K R G I Y K R T A V I Q E S E S H S K N G A K V E L P L S D T L A I K G K V I D V D H G I I C E N V P I I T P A G E V V A S R L N F K V E E G M H L L I T G P N G C G K S S L F R I L S G L W P V Y E G V L Y K P P P Q H M F Y I P Q R P Y M S L G S L R D Q V I Y P D S V D D M H D K G Y T D Q D L E R I L H N V H L Y H I V Q R E G G W D A V M D W K D V L S G G E K Q R M G M A R M F Y H K P K Y A L L D E C T S A V S I D V E G K I F Q A A K G A G I S L L S I T H R P S L W K Y H T H L L Q F D G E G G W R F E Q L D T A I R L T L S E E K Q K L E S Q L A G I P K M Q Q R L N E L C K I L G E D S V L K T I K N E D E T S
PTM type	X-Acetylation X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCD2			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	146
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ABCD2 Lysine 146 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCD2			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	149
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ABCD2 Lysine 149 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCD2			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	170
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ABCD2 Lysine 170 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCD2			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	378
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ABCD2 Lysine 378 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCD2			[5]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	190
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCD2 Asparagine 190 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCD2			[5]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	227
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCD2 Asparagine 227 has the potential to affect its expression or activity.
Oxidation
Cystine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCD2			[6]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	25
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ABCD2 Cystine 25 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCD2			[6]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	480
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ABCD2 Cystine 480 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCD2			[6]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	515
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ABCD2 Cystine 515 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCD2			[6]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	635
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ABCD2 Cystine 635 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCD2			[6]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	721
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ABCD2 Cystine 721 has the potential to affect its expression or activity.
Phosphorylation
Serine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCD2			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	447
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Serine 447 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCD2			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	449
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Serine 449 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCD2			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	451
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Serine 451 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCD2			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	462
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Serine 462 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCD2			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	519
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Serine 519 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCD2			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	556
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Serine 556 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCD2			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	705
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Serine 705 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCD2			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	71
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Threonine 71 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCD2			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	186
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Threonine 186 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCD2			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	390
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Threonine 390 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCD2			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	391
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Threonine 391 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCD2			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	414
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Threonine 414 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCD2			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	420
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Threonine 420 has the potential to affect its expression or activity.
Tyrosine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCD2			[13]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	410
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Tyrosine 410 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCD2			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	419
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Tyrosine 419 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCD2			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	424
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Tyrosine 424 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCD2			[16] , [17]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	670
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCD2 Tyrosine 670 has the potential to affect its expression or activity.
Ubiquitination
Lysine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCD2			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	411
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCD2 Lysine 411 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCD2			[20]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	456
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCD2 Lysine 456 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCD2			[16] , [21]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	517
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCD2 Lysine 517 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCD2			[18] , [22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	614
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCD2 Lysine 614 has the potential to affect its expression or activity.

References
1	A synthetic liquid medium for the development of the tissue form of Coccidiodes immitis at 26 degrees C. Mykosen. 1981 Sep;24(9):534-40.
2	Uracil in DNA in megaloblastic anemia. N Engl J Med. 1981 Nov 5;305(19):1156-7.
3	Rights of the dying incompetent patient. N Engl J Med. 1981 Nov 12;305(20):1222-3.
4	Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
5	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ABCD2_HUMAN)
6	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
7	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
8	Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
9	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
10	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
11	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
12	Study concerning the time-consuming, economic and psychological stress connected with having a severely retarded, homebound child between 6 and 14 years of age. Basic needs met only through considerable family effort. Sygeplejersken. 1979 Jul 27;79(25):16-21, 38.
13	Radiosensitization of human leukemic HL-60 cells by ATR kinase inhibitor (VE-821): phosphoproteomic analysis. Int J Mol Sci. 2014 Jul 7;15(7):12007-26.
14	Insights into chemoselectivity principles in metal oxide affinity chromatography using tailored nanocast metal oxide microspheres and mass spectrometry-based phosphoproteomics. Analyst. 2017 May 30;142(11):1993-2003.
15	Sleep apnoea syndromes. Lancet. 1979 Jan 6;1(8106):25-6.
16	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
17	Mineralization of blood pump bladders. Trans Am Soc Artif Intern Organs. 1981;27:708-13.
18	Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells. Proteomics. 2018 Aug;18(15):e1700388.
19	Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. J Biol Chem. 2011 Dec 2;286(48):41530-41538.
20	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
21	Global identification of modular cullin-RING ligase substrates. Cell. 2011 Oct 14;147(2):459-74.
22	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence